Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2019

View Archived Issues

How blood flows through bones

F-act-in stead of MMPs

Metabolism change stimulates macrophage appetite

FDA approves sNDA to add moderate to severe vaginal dryness to the indication of Osphena

Momenta begins phase I/II trial of M-254 for ITP

Bacterial metabolites enhance immune responses

Axsome Therapeutics initiates phase II CONCERT study of AXS-12 in narcolepsy

RESMAIN study of resminostat receives second positive safety review

Ebola virus disease macaque model developed to aim at FDA approval

Fexinidazole approved in Democratic Republic of Congo for the treatment of sleeping sickness

FDA issues complete response letter for Sunovion's apomorphine sublingual film

Daewoong Pharmaceutical discloses Bruton tyrosine kinase/tyrosine-protein kinase ITK/TSK inhibitors

Tachykinin receptor 3 antagonists synthesized at Ogeda

A*STAR identifies MAPK-interacting kinase 1 and 2 inhibitors

Valneva reports final phase I and initial booster data with Lyme disease vaccine candidate VLA-15

Bristol-Myers Squibb discovers Rho-associated protein kinase 2 inhibitors

aTyr enters research collaboration with University of Nebraska in support of ATYR-1923

Hepatitis B virus caspid assembly inhibitors patented by Shanghai Longwood Biopharmaceuticals

Interim results from phase III study of oral ibrexafungerp in refractory fungal infections

Vertex Pharmaceuticals patents sodium channel protein type 10 subunit alpha blockers

Phase II trial explores use of oral factor XIa inhibitor BMS-986177 for secondary stroke prevention

CONRAD enrolls women in Kenya to study tenofovir/levonorgestrel and tenofovir intravaginal rings

5AR targeting disrupts D1R-D3R heteromer formation and protects from dyskinesia in Parkinson's model

TLR3 unveiled as therapeutic target for treating pulmonary hypertension

Imprinting of nc886 DMR is mosaic in the population and influenced by maternal environment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...